imipramine has been researched along with pemoline in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (66.67) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, DE; L'Italien, YJ; Marriott, JG; Nordin, IC; Poschel, PH; Zweisler, L | 1 |
| Butler, DE; Marriott, JG; Poschel, BP | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Margolin, DI | 1 |
| Hung, W; Lipman, RS; Overall, JE; Roche, AF | 1 |
| White, JH | 2 |
| McDaniel, KD | 1 |
| Glasky, AJ; Simon, LN | 1 |
| Akinlaja, A; Opitz, K | 1 |
| Bouttier, D; Julou, L; Sigwald, J; Thomas, J | 1 |
| Bocknik, SE; Kulkarni, AS; Reitz, RH | 1 |
| Peters, JE | 1 |
| Gauthier, M | 1 |
| Abikoff, HB; Arnold, LE; Cantwell, DP; Conners, CK; Elliott, G; Greenhill, LL; Hechtman, L; Hinshaw, SP; Hoza, B; Jensen, PS; Kraemer, HC; March, JS; Newcorn, JH; Pelham, WE; Richters, JE; Schiller, E; Severe, JB; Swanson, JM; Vereen, D; Wells, KC | 1 |
| Persky, B; Sangal, JM; Sangal, RB | 1 |
| Boyle, M; Cunningham, C; Jadad, AR; Kim, M; Schachar, R | 1 |
5 review(s) available for imipramine and pemoline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The hyperkinetic child syndrome and brain monoamines: pharmacology and therapeutic implications.
Topics: Animals; Arousal; Attention; Brain; Child; Dextroamphetamine; Disease Models, Animal; Dopamine; Humans; Hyperkinesis; Imipramine; Methoxyhydroxyphenylglycol; Methylphenidate; Pemoline; Stereotyped Behavior | 1978 |
Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1).
Topics: Adolescent; Aggression; Antidepressive Agents; Antipsychotic Agents; Anxiety, Separation; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Developmental Disabilities; Diazepam; Histamine H1 Antagonists; Humans; Imipramine; Lithium; Mental Disorders; Methylphenidate; Pemoline; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Thioridazine | 1986 |
Stimulant medications in adults with attention deficit disorder.
Topics: Adolescent; Adult; Amitriptyline; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Dextroamphetamine; Double-Blind Method; Humans; Imipramine; Male; Methylphenidate; Pemoline; Prospective Studies; Secobarbital | 1984 |
Treatment of attention-deficit/hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior; Combined Modality Therapy; Desipramine; Dextroamphetamine; Evidence-Based Medicine; Follow-Up Studies; Humans; Imipramine; Methylphenidate; Nicotine; Nicotinic Agonists; Pemoline; Phenylalanine; Placebos; Randomized Controlled Trials as Topic; Safety; Treatment Outcome | 1999 |
2 trial(s) available for imipramine and pemoline
| Article | Year |
|---|---|
Stimulant medications in adults with attention deficit disorder.
Topics: Adolescent; Adult; Amitriptyline; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Dextroamphetamine; Double-Blind Method; Humans; Imipramine; Male; Methylphenidate; Pemoline; Prospective Studies; Secobarbital | 1984 |
National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices.
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Clinical Protocols; Combined Modality Therapy; Decision Making; Dextroamphetamine; Female; Health Policy; Health Services Research; Humans; Imipramine; Male; Methylphenidate; National Institute of Mental Health (U.S.); Patient Selection; Pemoline; Research Design; United States | 1997 |
15 other study(ies) available for imipramine and pemoline
| Article | Year |
|---|---|
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
Topics: Amnesia; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Humans; Male; Mice; Mice, Inbred Strains; Pyrrolidines; Structure-Activity Relationship | 1984 |
Cognition-activating properties of 3-(Aryloxy)pyridines.
Topics: Animals; Cognition; Dose-Response Relationship, Drug; Male; Mice; Psychotropic Drugs; Pyridines; Structure-Activity Relationship | 1981 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effects of stimulant medication on the growth of hyperkinetic children.
Topics: Adolescent; Body Height; Body Weight; Child Behavior Disorders; Dextroamphetamine; Growth; Growth Disorders; Humans; Hyperkinesis; Imipramine; Methylphenidate; Pemoline | 1979 |
The hyperactive child syndrome.
Topics: Child; Dextroamphetamine; Diphenhydramine; Humans; Hyperkinesis; Imipramine; Methylphenidate; Pemoline; Promethazine; Thioridazine | 1977 |
Methylphenidate (ritalin) and other drugs for treatment of hyperactive children.
Topics: Child; Deanol; Dextroamphetamine; Drug Interactions; Humans; Hyperkinesis; Imipramine; Methylphenidate; Pemoline; Phenytoin | 1977 |
Magnesium pemoline: enhancement of brain RNA polymerases.
Topics: Animals; Anticonvulsants; Brain; Imipramine; In Vitro Techniques; Magnesium; Methamphetamine; Methylphenidate; Nucleotidyltransferases; Oxazoles; Pargyline; Pemoline; Piperidines; Rats; RNA; Trimethadione | 1966 |
[On the influencing of food intake by psychotropic drugs].
Topics: Amitriptyline; Animals; Behavior, Animal; Body Weight; Central Nervous System; Central Nervous System Stimulants; Chlordiazepoxide; Chlorpromazine; Chlorprothixene; Eating; Feeding and Eating Disorders; Female; Haloperidol; Humans; Imipramine; Nutritional Physiological Phenomena; Oxazepam; Oxazoles; Pemoline; Phenobarbital; Piperidines; Promethazine; Psychopharmacology; Rats; Reserpine; Thiazines | 1966 |
[Therapy of hypersomnia].
Topics: Amphetamine; Animals; Antidepressive Agents; Appetite Depressants; Bemegride; Caffeine; Cats; Central Nervous System Stimulants; Chlorphentermine; Desipramine; Electroencephalography; Ephedrine; Glycolates; Humans; Hydroxybutyrates; Imipramine; Mice; Narcolepsy; Pemoline; Phentermine; Piperidines; Rabbits; Rats; Sleep Wake Disorders; Strychnine; Sympathomimetics | 1967 |
A comparison of Mg pemoline and (+)-amphetamine effects upon avoidance behaviour and the amine pump.
Topics: Amines; Animals; Avoidance Learning; Carbon Isotopes; Cerebral Cortex; Dextroamphetamine; Imipramine; In Vitro Techniques; Injections, Intraperitoneal; Magnesium; Male; Mice; Norepinephrine; Pemoline; Quinolizines; Reserpine; Tranquilizing Agents | 1972 |
Minimal brain dysfunctions in children.
Topics: Amphetamine; Attention; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Communication; Dyslexia; Emotions; Form Perception; Handwriting; Humans; Hyperkinesis; Imipramine; Intelligence Tests; Language Development; Learning Disabilities; Male; Methylphenidate; Motor Skills; Orientation; Pemoline; Psychomotor Disorders; Thioridazine | 1974 |
The hyperactive child in adolescence: some pharmacologic approaches.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child Behavior Disorders; Humans; Imipramine; Juvenile Delinquency; Male; Pemoline; Substance-Related Disorders | 1981 |
Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Brain Mapping; Central Nervous System Stimulants; Child; Event-Related Potentials, P300; Evoked Potentials, Auditory; Evoked Potentials, Visual; Female; Humans; Imipramine; Male; Pemoline; Reaction Time | 1996 |